Tobacco smoking, harm reduction, and nicotine product regulation

The Lancet

Volumn 371, Issue 9610, 2008, Pages 441-445

  Britton, John ^a   Edwards, Richard ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ARTICLE; CAUSE OF DEATH; CIGARETTE SMOKING; DISEASE CONTROL; HUMAN; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PRIORITY JOURNAL; SMOKELESS TOBACCO; TOBACCO DEPENDENCE; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

EID: 38649095930     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61482-2     Document Type: Note

References (40)

1. Peto R., and Lopez A. Future worldwide health effects of current smoking patterns. In: Koop C., Pearson C., and Schwarz M. (Eds). Critical issues in global health (2001), Wiley (Jossey-Bass), San Francisco 154-161
2. World Bank. Curbing the epidemic: governments and the economics of tobacco control (1999), World Bank, Washington DC
3. Doll R., Peto R., Wheatley K., Gray R., and Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309 (1994) 901-911
4. WHO. WHO framework convention on tobacco control (2003), World Health Organisation, Geneva
5. World Bank. Tobacco control at a glance. http://www1.worldbank.org/tobacco/pdf/AAG%20Tobacco%206-03.pdf (accessed July 27, 2007).
6. Royal College of Physicians. Smoking and health. A report on smoking in relation to lung cancer and other diseases (1962), Royal College of Physicians, London
7. Frieden T., and Bloomberg M. How to prevent 100 million deaths from tobacco. Lancet 369 (2007) 1758-1761
8. Pierce J., Gilpin E., Emery S., et al. Has the California tobacco control program reduced smoking?. JAMA 280 (1998) 893-899
9. Biener L., Harris J., and Hamilton W. Impact of the Massachusetts tobacco control programme: population based trend analysis. BMJ 321 (2000) 351-354
10. Centre for Epidemiology and Research. 2005 report on adult health from the New South Wales population health survey (2006), Department of Health, Sydney
11. Health Canada. Long-term trends in the prevalence of current smokers. http://www.hc-sc.gc.ca/hl-vs/tobac-tabac/research-recherche/stat/ctums-esutc/prevalence/chart_image_2006_e.html (accessed July 27, 2007).
12. Lader D. Smoking-related behaviour and attitudes, 2006 (2007), Office for National Statistics, Cardiff
13. Jarvis M., and Wardle J. Social patterning of individual health behaviours: the case of cigarette smoking. In: Marmot M., and Wilkinson R. (Eds). Social determinants of health (1999), Oxford University Press, Oxford
14. Tobacco Advisory Group of the Royal College of Physicians. Harm reduction for nicotine addiction (2007), Royal College of Physicians, London
15. Royal College of Physicians. Nicotine addiction in Britain. A report of the Tobacco Advisory Group of the Royal College of Physicians (2000), Royal College of Physicians, London
16. Balfour D. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine Tob Res 6 (2004) 899-912
17. Gentry C., and Lukas R. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1 (2002) 359-385
18. Breese C., Marks M., Logel J., et al. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282 (1997) 7-13
19. Benowitz N., and Gourlay S. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29 (1997) 1422-1431
20. Joseph A., Norman S., Ferry L., et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335 (1996) 1792-1798
21. Hubbard R., Lewis S., Smith C., et al. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 14 (2005) 416-421
22. Wisborg K., Henriksen T., Jespersen L., and Secher N. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96 (2000) 967-971
23. Critchley J., and Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 58 (2003) 435-443
24. Boffetta P., Aagnes B., Weiderpass E., and Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 114 (2005) 992-995
25. Luo J., Ye W., Zendehdel K., et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 369 (2007) 2015-2020
26. Broadstock M. Systematic review of the health effects of modified smokeless tobacco products (2007), New Zealand Health Technology Assessment, Christchurch
27. Teo K., Ounpuu S., Hawken S., et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368 (2006) 647-658
28. Roth D., Roth A., and Liu X. Health risks of smoking compared to Swedish snus. Inhal Toxicol 17 (2005) 741-748
29. Levy D., Mumford E., Cummings K., et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev 13 (2004) 2035-2042
30. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3 (2004) CD000146
31. Anderson J., Jorenby D., Scott W., and Fiore M. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest 121 (2002) 93241
32. West R., McNeill A., and Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 55 (2000) 98799
33. Siahpush M., McNeill A., Hammond D., and Fong G. Socioeconomic and country variations in knowledge of health risks of tobacco smoking and toxic constituents of smoke: results from the 2002 International Tobacco Control (ITC) Four Country Survey. Tob Control 15 (2006) iii65-iii70
34. Rodu B., Stegmayr B., Nasic S., and Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med 252 (2002) 398-404
35. Ramstrom L., and Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 15 (2006) 210-214
36. Nelson D., Mowery P., Tomar S., Marcus S., Giovino G., and Zhao L. Trends in smokeless tobacco use among adults and adolescents in the United States. Am J Public Health 96 (2006) 897-905
37. WHO. Tobacco: Deadly in any form or disguise (2006), World Health Organisation, Geneva
38. Levy D., Mumford E., Cummings K., et al. The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts. Addict Behav 31 (2006) 1190-1200
39. Gartner C., Hall W., Vos T., Bertram M., Wallace A., and Lim S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 369 (2007) 2010-2014
40. Kozlowski L. Harm reduction, public health, and human rights: smokers have a right to be informed of significant harm reduction options. Nicotine Tob Res 4 suppl 2 (2002) S55S60